References
- Stadberg E, Mattsson LA, Milsom I. Women's attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study. Maturitas 1997;2:109–16
- Dören M, Reuther G, Minne HNV, Schneider PG. Superior compliance and efficacy of continuous combined oral estrogens—progestogen replace-ment in postmenopausal women. Am J Obstet Gynecol 1995;173:1446–51
- MacLennan AH, MacLennan A, Wenzel S, Chambers FIM, Eckert K. Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomized trial. Med J Aust 1993; 159:102–6
- Eiken P, Kolthoff N. Compliance with long-term oral hormonal replacement therapy. Maturitas 1995;22:97–103
- Huber JC, Campagnoli C, Druckmann R, et al. Recommendations for estrogen and progestin replacement in the climacteric and postmeno-pause. Maturitas 1999;33:197–209
- Graziottin A. Strategies for effectively addressing women's concerns about the menopause and HRT. Maturitas 1999;33:S15–23
- Mattsson LA. Evaluation of a continuous oestrogen—progestogen regimen for climacteric complaints. Maturitas 1982;4:95–102
- Bruhat M, Rudolf K, Vaheri R, Kainulainen P, Timonen U, Viitanen A. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy. A randomised comparative dose-ranging study. Maturitas 2001;40:259–71
- Archer DF, Dorin M, Lewis V, Scheider DL, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding. Fertil Steril 2001;75:1080–7
- Mattsson L-A, Bohnet HG, Gredmark T, Torhorst J, Hornig F, Huls G. Continuous combined hormone replacement. Randomized comparison of transdermal and oral prepara-tions. Obstet Gynecol 1999;94:61–5
- Simon JA, Symons JP. Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct compari-son of two combinations of norethindrone acetate and ethinyl estradiol to medroxyproges-terone acetate and conjugated equine estrogens. Menopause 2001;8:321–7
- Archer DF, Pickar JH. Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding. Obstet Gynecol 2000;96:899–905
- Heikkinen J, Vaheri R, Ahomäki S, Kainulainen P, Viitanen A, Timonen U. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a compari-son of six different treatment regimens. Am J Obstet Gynecol 2000;182:560–7
- Heikkinen J, Vaheri R, Kainulainen P, Timonen U. Long-term continuous combined hormone replacement therapy in the prevention of post-menopausal bone loss: a comparison of high- and low-dose estrogen—progestin regimens. Osteo-poros Int 2000;11:929–37
- Campagnoli C, Biglia N, Cantamessa C, Lesca L, Sismondi P. HRT and breast cancer risk: a clue for interpreting the available data. Maturitas 1999;33:185–90
- Bülbül NH, Ozden S, Dayicioglu V. Effects of hormone replacement therapy on mammo-graphic findings. Arch Gynecol Obstet 2003; 268:5–8